MedPath

Determinants of Corticosteroid Insensitivity in Smokers With Asthma

Not Applicable
Completed
Conditions
Asthma
Smoking
Steroid Resistance
Corticosteroid Insensitivity
Interventions
Drug: oral steroid-dexamethasone
Registration Number
NCT00411320
Lead Sponsor
University of Glasgow
Brief Summary

Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. The investigators will perform a number of blood \& breathing tests to try to discover the cause/s behind this phenomenon with the aim of producing leads for further investigation and possible new treatments for smokers with asthma.

Detailed Description

Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. However research into steroid resistance in severe asthma and the smoking related condition chronic obstructive pulmonary disease (COPD) points to a number of possible causes. We will characterise a group of smokers with asthma and perform a number of investigations and compare the results to ex-smokers and never smokers with asthma with the aim of establishing which previously published steroid resistance phenomena are related to the steroid resistance displayed by smokers with asthma. Results produced from this trial will provide hypothesis generating information leading to future pharmaceutical trials.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria
  • Asthma (defined by either reversibility to bronchodilator or methacholine testing)

  • Asthma duration of 6 months or greater

  • Stable asthma

  • Age 18-60

  • Treatment with inhaled corticosteroids

  • Smoking history consistent with group

    • smokers with asthma: > or = 5 pack years and currently smoking more than 5 cigarettes per day
    • ex-smokers: smoking ceased > or = two years prior to recruitment, minimum 5 pack year history
    • non-smokers: no smoking history
Exclusion Criteria
  • Presence of medical condition likely to be exacerbated by treatment with oral corticosteroids
  • Treatment with > 2000 mcg beclomethasone (or equivalent) per day
  • Subject requires oral corticosteroids to maintain asthma control
  • Subject requires oral theophylline to maintain asthma control
  • Recent treatment with oral corticosteroids
  • Pregnancy or subject planning to become pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group 1oral steroid-dexamethasoneSmokers with asthma
Group 2oral steroid-dexamethasoneEx-smokers with asthma
Group 3oral steroid-dexamethasoneNon-smokers with asthma
Primary Outcome Measures
NameTimeMethod
bronchodilator response to oral corticosteroid trial in smokers with asthma vs non smokers and ex-smokers with asthma2 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asthma Research Unit, Glasgow University

🇬🇧

Glasgow, Scotland, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath